Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease.
Department of Respiratory Diseases, University of Bari, Bari, Italy E-mail: silvano.dragonieri@uniba.it.
Silvano
S
Dragonieri
Department of Respiratory Diseases, University of Bari, Bari, Italy E-mail: silvano.dragonieri@uniba.it.
Vitaliano N
VN
Quaranta
Department of Respiratory Diseases, University of Bari, Bari, Italy E-mail: silvano.dragonieri@uniba.it.
Pierluigi
P
Carratu
Department of Respiratory Diseases, University of Foggia, Foggia, Italy.
Donato
D
Lacedonia
Department of Respiratory Diseases, University of Foggia, Foggia, Italy.
Giovanna Elisiana
GE
Carpagnano
Department of Respiratory Diseases, University of Bari, Bari, Italy E-mail: silvano.dragonieri@uniba.it.
Annamaria
A
Milano
Department of Respiratory Diseases, University of Bari, Bari, Italy E-mail: silvano.dragonieri@uniba.it.
Giuseppina
G
D'Alba
Department of Respiratory Diseases, University of Bari, Bari, Italy E-mail: silvano.dragonieri@uniba.it.
Teresa
T
Ranieri
Department of Respiratory Diseases, University of Foggia, Foggia, Italy.
Maria Pia Foschino
MP
Barbaro
Department of Respiratory Diseases, University of Bari, Bari, Italy E-mail: silvano.dragonieri@uniba.it.
Onofrio
O
Resta